Clinical Trials Logo

Filter by:
NCT ID: NCT03805685 Completed - Cognitive Change Clinical Trials

Preoperative Risk Factors and Perioperative Neurocognitive Disorders

Start date: February 3, 2019
Phase:
Study type: Observational

Perioperative neurocognitive disorders (PND's) remain an important complication after surgery. After many years of speculating about the etiology of this complication, currently studies are pointing to an inflammatory cascade being set in motion. This prospective study is designed to examine preoperative lifestyle factors (such as sedentary behavior) associated with postoperative cognitive impairment in a group of patients undergoing non-cardiac surgery. The objectives in our study are to: identify perioperative risk factors for the development of PND's measure the incidence and duration of perioperative neurocognitive disorders in a known high-risk group of elective surgical patients measure a peripheral inflammatory marker (interleukin 6: IL-6) in the same group of surgical patients

NCT ID: NCT03803800 Completed - Multiple Sclerosis Clinical Trials

Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis

MSCAR
Start date: January 9, 2019
Phase: N/A
Study type: Interventional

Exercise therapy and increased physical activity in persons with Multiple Sclerosis (MS) improves mobility, muscular strength, physical fitness and fatigue without increasing relapse rate. As such, physical activity and more particular exercise therapy have become an important part of MS rehabilitation. Despite the fact that the positive effects of exercise therapy in MS are obvious only 43 percent of the MS community reports to participate in an exercise program4. Therefore, new exercise therapy approaches that further optimize rehabilitation, improve exercise adherence and promote participation in physical exercise in MS are interesting to explore. Therefore, the randomized controlled trial investigates two types of exercise interventions (classic progressive vs periodized) with or without the addition of ergogenic supplements (beta-alanine vs placebo).

NCT ID: NCT03802682 Completed - Healthy Clinical Trials

A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy Participants

Start date: January 11, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the bioavailability of apalutamide tablets administered orally as dispersed tablets mixed in applesauce relative to whole tablets under fasting conditions in healthy male participants.

NCT ID: NCT03800550 Completed - Healthy Clinical Trials

A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult Participants

Start date: February 13, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effect of steady-state clarithromycin once every 12 hour on the pharmacokinetic parameters of bedaquiline and its active metabolite M2 after a single dose of bedaquiline.

NCT ID: NCT03799822 Completed - Atrial Fibrillation Clinical Trials

Oral Anticoagulation in Hemodialysis

Start date: May 1, 2017
Phase: Phase 4
Study type: Interventional

The investigators refer to the trial with clinicaltrials.gov indentifier NCT02610933 entitled Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients. After termination of this trial, included patients will be asked to participate in the extension trial by continuing the treament of their respective allocation arm. No new intervention will be done.

NCT ID: NCT03799731 Completed - Colorectal Cancer Clinical Trials

Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal Cancers

Start date: July 11, 2018
Phase: Phase 2
Study type: Interventional

Phase 2A study, assessing the antitumor activity and the safety profile of GM102, a new compound (monoclonal antibody), administered alone or in combination with chemotherapy in patients with locally advanced or metastatic colorectal cancer. The primary objective of the study is to evaluate the antitumor activity of GM102 single agent and in combination with trifluridine/tipiracil.

NCT ID: NCT03799146 Completed - Overweight Clinical Trials

Identifying the Effect and Working Mechanisms of MyPlan 2.0 in Older Adults

Start date: January 15, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to investigate whether and how 'MyPlan 2.0' helps older adults to be more physically active or less sedentary. Two groups will be created, an intervention group and a waiting-list control group.

NCT ID: NCT03798366 Completed - Systemic Sclerosis Clinical Trials

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis

NOVESA
Start date: January 14, 2019
Phase: Phase 2
Study type: Interventional

The main purpose of the study is to see if GLPG1690 helps (together with the standard of care treatment) in the treatment of the skin and other areas affected by systemic sclerosis. Another aim is to find out how safe/well tolerated GLPG1690 will be and whether there are any side effects. The study will also look at other things, including whether the study drug affects disease progression and also if it changes any aspect of the quality of life.

NCT ID: NCT03798262 Completed - Clinical trials for Healthy Volunteers, Gluten

Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Healthy Subjects

Start date: February 16, 2017
Phase: N/A
Study type: Interventional

The investigators will investigate the effects of acute and sub-acute administration of gluten on mood, intestinal permeability, gastrointestinal symptoms and gut peptide levels in healthy volunteers (HV).

NCT ID: NCT03797937 Completed - Multiple Sclerosis Clinical Trials

Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

The goal of this longitudinal study is to (1) explore the association between the gut microbiota and inflammatory disease activity in early onset multiple sclerosis, (2) investigate whether/how gut microbial composition vary when patients experience a relapse, and (3) to assess whether the gut microbiota shows increased similarities between affected pairs of first-degree relatives within the same family when compared with discordant pairs of first-degree relatives.